SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-701350
Filing Date
2016-09-06
Accepted
2016-09-06 07:07:02
Documents
3
Period of Report
2016-09-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d230734d8k.htm 8-K 13081
2 EX-99.1 d230734dex991.htm EX-99.1 37987
3 GRAPHIC g230734snap1.jpg GRAPHIC 9870
  Complete submission text file 0001193125-16-701350.txt   65906
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 161869840
SIC: 2834 Pharmaceutical Preparations